Table 2

Distribution of genotypes in COPD and control subjects

Leu-LeuLeu-ProPro-Pro
COPD patients (n = 165)69 (41.6%)83 (50.0%)13 (8.4%)
Blood donors (n = 140)41 (29.3%)73 (52.1%)26 (18.6%)
Resistant smokers (n = 76)22 (28.9%)39 (51.3%)15 (19.7%)